Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma.

International journal of immunopathology and pharmacology(2023)

引用 0|浏览1
暂无评分
摘要
Our findings for the first time constructed a robust IRGs-based signature to precisely predict risk of recurrence and further provided a deeper understanding of IRGs regulatory mechanism in LSCC pathogenesis.
更多
查看译文
关键词
Laryngeal squamous cell carcinoma,immune-related genes,recurrence-free survival,signature
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要